Xu Peipei, Xia Xiaotian, Yang Zhili, Tian Yuan, Di Jianzhong, Guo Minggao
Department of Surgery, The Sixth People's Hospital of Shanghai, Shanghai Jiaotong University, Shanghai 200233, P.R. China.
Department of Surgery, The People's Hospital of Xigaze, 857000 Tibet, P.R. China.
Exp Ther Med. 2017 Oct;14(4):3720-3726. doi: 10.3892/etm.2017.4940. Epub 2017 Aug 16.
Tectonic family member 1 (TCTN1) is one of the tectonic family members, and a regulator of the hedgehog signaling pathway, which has been studied in various cancer types, including prostate and pancreatic cancer. However, its function in thyroid cancer has not been well documented. Therefore, the present study investigated the function of TCTN1 in thyroid cancer using a loss-of-function assay. Lentivirus-mediated RNA interference was applied to downregulate TCTN1 in the thyroid cancer cell lines, CAL62 and 8305C. A series of functional properties, including cell viability, colony formation, cell cycle and apoptosis were determined using MTT, colony formation assay and flow cytometry analyses, respectively. The results demonstrated that lentivirus-medicated RNAi could specifically suppress the expression of TCTN1 at the mRNA and protein levels in CAL62, and 8305C cells. Knockdown of TCTN1 inhibited cell growth and proliferation via inducing S phase arrest, and apoptosis. Mechanistically, the S phase arrest was accompanied by the upregulation of cyclin dependent kinase 2, cyclin A2 and downregulation of cyclin B1. Knockdown of TCTN1 induced apoptosis through increasing the expression of Bcl2-associated agonist of cell death, cleaved caspase-3 and poly(ADP-ribose)polymerase, and decreasing apoptosis regulator Bcl-2 expression. The current study highlights the essential role of TCTN1 in promoting thyroid cancer cell proliferation, and its knockdown may serve as a potential therapeutic treatment for thyroid cancer.
构造家族成员1(TCTN1)是构造家族成员之一,也是刺猬信号通路的调节因子,已在包括前列腺癌和胰腺癌在内的多种癌症类型中进行了研究。然而,其在甲状腺癌中的功能尚未得到充分记录。因此,本研究使用功能丧失试验研究了TCTN1在甲状腺癌中的功能。采用慢病毒介导的RNA干扰技术下调甲状腺癌细胞系CAL62和8305C中的TCTN1。分别使用MTT、集落形成试验和流式细胞术分析确定了一系列功能特性,包括细胞活力、集落形成、细胞周期和凋亡。结果表明,慢病毒介导的RNAi可在mRNA和蛋白质水平上特异性抑制CAL62和8305C细胞中TCTN1的表达。敲低TCTN1通过诱导S期阻滞和凋亡来抑制细胞生长和增殖。机制上,S期阻滞伴随着细胞周期蛋白依赖性激酶2、细胞周期蛋白A2的上调和细胞周期蛋白B1的下调。敲低TCTN1通过增加细胞死亡的Bcl2相关激动剂、裂解的半胱天冬酶-3和聚(ADP-核糖)聚合酶的表达以及降低凋亡调节因子Bcl-2的表达来诱导凋亡。当前研究强调了TCTN1在促进甲状腺癌细胞增殖中的重要作用,敲低它可能成为甲状腺癌的一种潜在治疗方法。